Consequences of CYP3A4 and MDR-1 polymorphisms on pharmakokinetic parameters of cyclosporin a and mycophenolic acid in pediatric renal transplant recipients.

被引：0
|
作者：
Feneberg, Reinhard
Weber, Lutz T.
van Asen, Nicolas
Armstrong, Victor W.
Hoecker, Britta
Oellerich, Michael
Toenshoff, Burkhard
机构：
[1] Univ Heidelberg, Dept Pediat Nephrol, Heidelberg, Germany
[2] Univ Munich, Dept Pediat Nephrol, Munich, Germany
[3] Univ Gottingen, Dept Clin Chem, D-3400 Gottingen, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
849
引用
收藏
页码：366 / 367
页数：2
相关论文
共 50 条
  • [1] Consequences of CYP3A4 and MDR-1 polymorphisms on pharmakokinetic parameters of cyclosporin a and mycophenolic acid in pediatric renal transplantation recipients
    Feneberg, R.
    Weber, L.
    Van Asen, N.
    Armstrong, V.
    Hoecker, B.
    Oellerich, M.
    Toenshoff, B.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1588 - 1588
  • [2] Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
    Shi, Yunying
    Li, Yi
    Tang, Jiangtao
    Zhang, Junlong
    Zou, Yuangao
    Cai, Bei
    Wang, Lanlan
    GENE, 2013, 512 (02) : 226 - 231
  • [3] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [4] Measurement of plasma mycophenolic acid in pediatric renal transplant recipients.
    McBride, JH
    Kim, S
    Reyes, A
    Rodgerson, DO
    CLINICAL CHEMISTRY, 1998, 44 : A93 - A93
  • [5] Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients
    Chowbay, B
    Cumaraswamy, S
    Cheung, YB
    Zhou, QY
    Lee, EJD
    PHARMACOGENETICS, 2003, 13 (02): : 89 - 95
  • [6] Time dependent expression of MDR-1 in stable male renal transplant recipients.
    Tornatore, K
    Brazeau, D
    Dole, K
    Gillis, K
    Leca, N
    Yassa, S
    Venuto, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P62 - P62
  • [7] Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic-polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes
    Hesselink, DA
    van Gelder, T
    van Schaik, RHN
    Balk, AHMM
    van der Heiden, IP
    van Dam, T
    van der Werf, M
    Weimar, W
    Mathot, RAA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (06) : 545 - 556
  • [8] Long-term (3 years) pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients.
    Weber, Lutz T.
    Hoecker, Britta
    Armstrong, Victor W.
    Oellerich, Michael
    Toenshoff, Burkhardt
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 366 - 366
  • [9] IMPACT OF CYP3A5, CYP3A4 AND MDR1 GENE POLYMORPHISMS ON TROUGH CONCENTRATIONS OF TACROLIMUS, CYCLOSPORINE AND SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Shi, Yunying
    Li, Yi
    Cai, Bei
    Cai, Bei
    Zou, Yuangao
    Tao, Ye
    Wang, Lanlan
    TRANSPLANT INTERNATIONAL, 2013, 26 : 84 - 84
  • [10] Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients
    Xiao-yan Qiu
    Zheng Jiao
    Ming Zhang
    Long-jin Zhong
    Hui-qi Liang
    Chun-lai Ma
    Liang Zhang
    Ming-kang Zhong
    European Journal of Clinical Pharmacology, 2008, 64
12345